Weight loss and hair loss: The growing hair treatment market from GLP-1s
When Branneisha Cooper first began taking GLP-1 injection Mounjaro in late 2022, she heard online that she could experience temporary ...
Tag: Eli Lilly and Co
Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
After years of trying to lose weight "the right way," Jane Zuckerman realized that "putting in the work just wasn't ...
Trump administration sets up to 100% tariffs on some imported drugs, with many companies exempt
The Trump administration on Thursday imposed new tariffs on branded drugs from pharmaceutical companies that have not struck deals with ...
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21, 2025.Mike Blake ...
U.S. executives, from Apple to Eli Lilly, revamp their push into the world’s second-largest economy at the China Development Forum
Apple CEO Tim Cook (L) stands with Siemens CEO Roland Busch prior to the opening ceremony of the China Development ...
GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up
A mini burger, mini fries and mini beer, Clinton Hall's "Teeny Weeny Mini Meal", is pictured next to a regular-sized ...
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
Eli Lilly on Thursday said its next-generation obesity drug retatrutide cleared its first late-stage trial on Type 2 diabetes patients, ...
Here are 3 major moments that drove the stock market last week
A massive market snapback on Friday couldn't erase all of the week's damage. After several days of selling, the tech ...
White House launches direct-to-consumer drug site TrumpRx. Here’s what to know
President Donald Trump makes an announcement from the Oval Office at the White House in Washington, Nov. 6, 2025.Jonathan Ernst ...
Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for ...
